J1805 HCPCS code: Injection, esmolol hydrochloride, 10 mg
J1805 is the HCPCS Level II code for injection, esmolol hydrochloride, 10 mg. In 2024 Medicare paid an average of $0.18 per service for J1805 across 413 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume rose 694% from 2023 to 2024 (52 to 413 services). In 2024, about 25 clinicians billed Medicare for J1805 for 108 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-01-01 |
Who bills J1805 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 25 |
| Medicare beneficiaries | 108 |
| States with claims | 4 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1805, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 52 | 20 | $0.24 | $0.19 |
| 2024 | 413 | 108 | $0.23 | $0.18 |
States with the most J1805 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| North Carolina | 120 | $0.18 |
| Mississippi | 115 | $0.19 |
| Louisiana | 51 | $0.16 |
| New York | 14 | $0.20 |
What changed for J1805
- 2023-07-01: J1805 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1805?
J1805 is the HCPCS Level II code for injection, esmolol hydrochloride, 10 mg. Short descriptor: "Inj, esmolol hcl, 10mg".
How much does Medicare pay for J1805?
In 2024, the average Medicare payment was $0.18 per service (average allowed $0.23).
Does Medicare cover J1805?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J18 codes
- J1800 — Injection, propranolol hcl, up to 1 mg
- J1806 — Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
- J1807 — Injection, ethacrynate sodium, 1 mg
- J1808 — Injection, folic acid, 0.1 mg
- J1809 — Injection, fosdenopterin, 0.1 mg
- J1810 — Injection, droperidol and fentanyl citrate, up to 2 ml ampule
- J1811 — Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
- J1812 — Insulin (fiasp), per 5 units
- J1813 — Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units
- J1814 — Insulin (lyumjev), per 5 units
- J1815 — Injection, insulin, per 5 units
- J1817 — Insulin for administration through dme (i.e., insulin pump) per 50 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1805
- Watch J1805 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1805
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.